`BIB_052`

Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. NEJM 2010;363(8):711–723. PMID 20525992. Ipilimumab Phase III — first ICI with OS benefit in melanoma. [Tasks: L, 18] Tier: 2 Grade: A Retrieved: 2026-05-06

Evidence grade: A
Tier: 2
Cited by tasks: L, 18
Identifiers: PMID:20525992

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_052/findings.md (research corpus). This page is a short context summary — not individualised medical advice.